Karol Marschollek

Neurology Department,
Wroclaw Medical University

[Marta Waliszewska-Prosół @MartaWaliszews1]

We found an overall high prevalence of primary headaches in children and adolescents. Thanks to @Simona_Sacco_ , SAS-EHF Fellows and @P_Martelletti and @EHF_Official https://t.co/o0sgv15MsU

[Marta Waliszewska-Prosół @MartaWaliszews1]

Does stopping migraine prophylaxis make sense? Thanks to @L_AlHassany @H_SLyons and @UweReuter3 🧠@EHF_Official and @P_Martelletti https://t.co/eE6EZk1qbh

[Stroke: Vascular and Interventional Neurology @SVINJournal]

Which IV crystalloid fluid 💧is better for subarachnoid hemorrhage (SAH)?

Mortality & 90-day mRS favored saline over balanced crystalloids in this subgroup of SAH pt in the SMART trial.

Read here: https://t.co/oiECCL8rVq

[European Stroke Org @ESOstroke]

Just posted - the ESO expedited recommendation for the use of short-term dual antiplatelet therapy early after minor #stroke and high-risk TIA: https://t.co/KjDiAPCCT1
@ProfJDawson @CatarinaACF
P.S. More #TIA guidelines coming soon.

[Karol Marschollek @KarolM94]

I am so happy I had the opportunity to take part in 8th ESO Edinburgh Stroke Research Workshop! So many inspirational talks and practical, interactive sessions!Developing a project idea from scratch was a great (and challenging) experience :) Thank you! @ESOstroke #eesrw2021